XML 73 R59.htm IDEA: XBRL DOCUMENT v3.23.2
Goodwill and Intangible Assets (Summary of Intangible Assets) (Details) - USD ($)
$ in Thousands
6 Months Ended
Apr. 21, 2023
Jun. 30, 2023
Dec. 31, 2022
Dec. 31, 2021
Definite-lived intangible assets        
Weighted-Average Life (Years)   23 years 11 years  
Finite-Lived Intangible Assets, Gross   $ 602,826 $ 11,488  
Accumulated Amortization   9,613 6,541  
Finite-Lived Intangible Assets, Net   593,213 4,947  
Indefinite-lived intangible assets        
Goodwill recognized   3,165 3,126 $ 3,313
Subtotal, Original Cost   32,390 32,351  
Subtotal, Net Book Value   32,390 32,351  
Balance, Original Cost   635,216 43,839  
Balance, Net Book Value   625,603 37,298  
Impairment of Long-Lived Assets to be Disposed of   2,700    
Finished Pharmaceutical Products Segment [Member]        
Indefinite-lived intangible assets        
Goodwill recognized   3,165 3,126  
Trademarks        
Indefinite-lived intangible assets        
Indefinite-lived intangible assets   $ 29,225 $ 29,225  
BAQSIMI product rights        
Definite-lived intangible assets        
Weighted-Average Life (Years)   24 years    
Finite-Lived Intangible Assets, Gross   $ 591,338    
Finite-Lived Intangible Assets, Net   $ 591,338    
Indefinite-lived intangible assets        
Estimated useful life of acquired intangible asset 24 years      
Patents        
Definite-lived intangible assets        
Weighted-Average Life (Years)   12 years 12 years  
Finite-Lived Intangible Assets, Gross   $ 486 $ 486  
Accumulated Amortization   369 362  
Finite-Lived Intangible Assets, Net   $ 117 $ 124  
Land-Use Rights [Member]        
Definite-lived intangible assets        
Weighted-Average Life (Years)   39 years 39 years  
Finite-Lived Intangible Assets, Gross   $ 2,540 $ 2,540  
Accumulated Amortization   782 749  
Finite-Lived Intangible Assets, Net   1,758 $ 1,791  
International Medication Systems (UK) Limited | Acquired international product rights        
Indefinite-lived intangible assets        
Impairment of Long-Lived Assets to be Disposed of   $ 2,700    
International Medication Systems (UK) Limited | Acquired international product rights        
Definite-lived intangible assets        
Weighted-Average Life (Years)   10 years 10 years  
Finite-Lived Intangible Assets, Gross   $ 8,462 $ 8,462  
Accumulated Amortization   $ 8,462 5,430  
Finite-Lived Intangible Assets, Net     $ 3,032  
BAQSIMI product rights        
Indefinite-lived intangible assets        
Payment to acquire assets $ 500,000      
Estimated useful life of acquired intangible asset   24 years